This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Teva Pharmaceuticals International Gmbh, Assia Chemical Industries Ltd.. Active years: 2020-2025.
Company Filing History:
2 out of 54 
1 out of 41 Years Active: 2020-2025
Title: David Lukas: Innovator in Pharmaceutical Chemistry
Introduction
David Lukas is a notable inventor based in Blovice, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of solid-state forms of Ixazomib Citrate. With a total of 3 patents to his name, Lukas has established himself as a key figure in the industry.
Latest Patents
Lukas's latest patents include innovative formulations of Ixazomib Citrate. The first patent details solid-state forms of Ixazomib Citrate and pharmaceutical compositions thereof. It also outlines processes for the preparation of Ixazomib Citrate. The second patent reiterates similar advancements in solid-state forms of Ixazomib Citrate, emphasizing the importance of these formulations in pharmaceutical applications.
Career Highlights
Throughout his career, David Lukas has worked with prominent companies in the pharmaceutical sector. Notably, he has been associated with Teva Pharmaceuticals International GmbH and Assia Chemical Industries Ltd. His work in these organizations has contributed to the advancement of pharmaceutical technologies and innovations.
Collaborations
Lukas has collaborated with several professionals in his field, including Martin Valik and Roman Gabriel. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
David Lukas is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug formulation. His contributions, particularly in the area of Ixazomib Citrate, highlight his expertise and commitment to innovation in the pharmaceutical industry.